<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert C Hyzy, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jakob I McSparron, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Polly E Parsons, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Geraldine Finlay, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 08, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Noninvasive ventilation (NIV) refers to the delivery of positive pressure ventilation through a noninvasive interface (eg, nasal mask, face mask, or nasal plugs), rather than an invasive interface (endotracheal tube, tracheostomy).
        </p>
        <p>
         NIV can be used as ventilatory support for patients with acute or chronic respiratory failure. Data that support NIV use in adult patients with
         <strong>
          acute
         </strong>
         respiratory failure are discussed here. The practical aspects of initiating NIV in patients with acute respiratory failure and use of NIV for treating chronic respiratory failure (eg, neuromuscular disorders, chest wall disease, or obesity hypoventilation syndrome) are described separately. (See
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7714.html" rel="external">
          "Noninvasive positive airway pressure therapy for the obesity hypoventilation syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5114.html" rel="external">
          "Noninvasive ventilation in adults with chronic respiratory failure from neuromuscular and chest wall diseases: Patient selection and alternative modes of ventilatory support"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H96523994">
         <span class="h1">
          CHOOSING NONINVASIVE VERSUS INVASIVE VENTILATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who present with acute respiratory failure, general principles that underlie the decision to choose NIV or invasive mechanical ventilation include the following [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          The presence of conditions that are typically responsive to NIV
         </strong>
         – In general, provided no contraindications are present, a short trial of NIV is justified in most patients with acute hypercapnic respiratory failure due to an acute exacerbation of chronic obstructive pulmonary disease and patients with acute cardiogenic pulmonary edema. Patients with other etiologies are less likely to benefit. Importantly, since delayed mechanical ventilation is associated with a poor outcome, trials of NIV should be short (eg, two hours or less); during NIV patients should be monitored and assessed frequently to ensure rapid intubation, when needed. Factors that predict success are listed in the table  (
         <a class="graphic graphic_table graphicRef59165" href="/z/d/graphic/59165.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Patients likely to benefit'
         </a>
         below and
         <a class="local">
          'Patients less likely to benefit'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          The presence of contraindications to NIV (including the emergent need for intubation)
         </strong>
         – The contraindications to NIV are listed on the table  (
         <a class="graphic graphic_table graphicRef60442" href="/z/d/graphic/60442.html" rel="external">
          table 2
         </a>
         ). The need for emergent intubation is an absolute contraindication and all others are relative or many have exceptions. In such cases, discussion with experts in NIV is appropriate so that an informed decision can be made to implement NIV. (See
         <a class="local">
          'Contraindications'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/268.html" rel="external">
          "The decision to intubate"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          The values and preferences of the patient
         </strong>
         – When feasible, the advantages and disadvantages of a noninvasive approach compared with an invasive approach should be explained to the patient or their caregiver. The major benefit of NIV is the avoidance of intubation and the attendant risks of invasive mechanical ventilation. For example, NIV appears to decrease the incidence of nosocomial infections likely as a consequence of fewer ventilator-associated pneumonias due to avoidance of intubation; NIV may also decrease the incidence of other nosocomial infections (eg, sinusitis, line sepsis) due to a shorter length of stay and shorter duration of invasive monitoring [
         <a href="#rid2">
          2
         </a>
         ]. Complications are few, are generally minor, and are often related to the interface (eg, local irritation or ulceration, air leaks, nasal dryness or congestion, gastric distension and aspiration). Barotrauma is rare. The major disadvantages of NIV compared with invasive mechanical ventilation are that it can be poorly tolerated in an awake patient, ventilation may be less effective due to air leaks, and it should only be used for short periods (eg, 24 hours to a few days). (See
         <a class="medical medical_review" href="/z/d/html/1628.html" rel="external">
          "Clinical and physiologic complications of mechanical ventilation: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Complications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1644.html" rel="external">
          "Complications of the endotracheal tube following initial placement: Prevention and management in adult intensive care unit patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/260.html" rel="external">
          "Direct laryngoscopy and endotracheal intubation in adults", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Choosing between high-flow oxygen delivered via nasal cannulae (HFNC) and NIV in hypoxemic patients is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/114077.html" rel="external">
          "Heated and humidified high-flow nasal oxygen in adults: Practical considerations and potential applications", section on 'General principles of application'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          PATIENTS LIKELY TO BENEFIT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Conditions known to respond well to NIV include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) that are complicated by hypercapnic acidosis (arterial carbon dioxide tension [PaCO
         <sub>
          2
         </sub>
         ] &gt;45 mmHg [6 kPa] or pH &lt;7.35) (see
         <a class="local">
          'Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with hypercapnic respiratory acidosis'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute cardiogenic pulmonary edema (ACPE) (see
         <a class="local">
          'Acute cardiogenic pulmonary edema (ACPE)'
         </a>
         below)
        </p>
        <p>
        </p>
        <p>
         NIV use in AECOPD has increased over time [
         <a href="#rid3">
          3
         </a>
         ] but despite clear evidence of efficacy, it may still be underutilized [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2371721723">
         <span class="h2">
          Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with hypercapnic respiratory acidosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with AECOPD complicated by hypercapnic (ie, respiratory) acidosis (PaCO
         <sub>
          2
         </sub>
         &gt;45 mmHg [6 kPa] or pH &lt;7.35), we recommend an initial trial of bilevel NIV (also known as bilevel positive airway pressure [BPAP]). Evidence from large randomized trials and meta-analyses consistently indicates that bilevel NIV improves important clinical outcomes in patients having an AECOPD complicated by hypercapnic acidosis [
         <a href="#rid1">
          1,5-9
         </a>
         ]. For example, one meta-analysis of 17 randomized trials of patients with AECOPD and acute hypercapnia (PaCO
         <sub>
          2
         </sub>
         &gt;45 mmHg [6 kPa]) reported an almost 50 percent reduction in mortality in patients treated with NIV plus standard therapy compared with standard therapy alone (18 versus 10 percent; risk ratio [RR] 0.54, 95% CI 0.38-0.76; number needed to treat for benefit [NNTB] 12) [
         <a href="#rid9">
          9
         </a>
         ]. Bilevel NIV also reduced the rate of intubation by 65 percent (12 versus 34 percent; RR 0.36, 95% CI 0.28 to 0.46; NNTB 5) as well as hospital length of stay, complications unrelated to NIV (eg, ventilator-associated pneumonia, multiorgan failure), and indices of gas exchange. The mechanism by which bilevel NIV improves hypercapnic respiratory failure in AECOPD is due to improved alveolar ventilation as evidenced by improved respiratory mechanics (eg, decreased respiratory rate, an increased tidal volume, and an increased minute ventilation) and improved gas exchange parameters (eg, increase in arterial oxygen tension [PaO
         <sub>
          2
         </sub>
         ] and decrease in the PaCO
         <sub>
          2
         </sub>
         ) [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         While data in the past suggested that patients with severe exacerbations were more likely to benefit from bilevel NIV [
         <a href="#rid6">
          6,11,12
         </a>
         ], a 2017 Cochrane analysis of 17 trials reported no differences between those with mild (defined as a pH between 7.3 and 7.35) or severe exacerbations (defined by those with a pH &lt;7.3) [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         While bilevel NIV is the mode of choice, continuous positive airway pressure (CPAP), pressure support ventilation (PSV), and other modes (eg, neurally adjusted ventilatory assist [NAVA]) have also been shown to result in success in patients with acute hypercapnic respiratory failure due to AECOPD [
         <a href="#rid1">
          1,5-9,13,14
         </a>
         ]. However, these modes are less likely to improve alveolar ventilation and do not have a strong body of evidence to support their use in patients with AECOPD. Modes like PSV and NAVA may be suitable for those who find bilevel NIV uncomfortable or who are dyssynchronous with the ventilator. (See
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Uncommon modes'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Rarely used modes'
         </a>
         .)
        </p>
        <p>
         The practical aspects of applying bilevel NIV, the potential role for nocturnal NIV in COPD, and the medical management of AECOPD are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Bilevel noninvasive ventilation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1453.html" rel="external">
          "Nocturnal ventilatory support in COPD"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1461.html" rel="external">
          "COPD exacerbations: Management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7019.html" rel="external">
          "Management of infection in exacerbations of chronic obstructive pulmonary disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H725964275">
         <span class="h2">
          Acute cardiogenic pulmonary edema (ACPE)
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mechanism by which NIV improves ACPE is thought to be due to preload reduction, the prevention of alveolar collapse at end expiration, and decreased left ventricular afterload. For patients with ACPE, we recommend a trial of NIV, typically with CPAP. Meta-analyses of small randomized trials in patients with ACPE, report that NIV decreases the need for intubation, improves clinical and laboratory indices of respiratory failure (eg, heart rate, dyspnea, hypercapnia, acidosis), and improves mortality [
         <a href="#rid1">
          1,7,15-23
         </a>
         ]. As an example, a 2013 meta-analysis of 32 studies (2916 patients) that included both modalities of NIV (CPAP and bilevel), reported that NIV significantly reduced hospital mortality in patients with ACPE compared with standard medical care (RR 0.66, 95% CI 0.48-0.89) [
         <a href="#rid21">
          21
         </a>
         ]. NIV also reduced rates of endotracheal intubation (RR 0.52, 95% CI 0.36 to 0.75) but did not have any impact on hospital length of stay. We prefer to use CPAP as initial therapy in patients with ACPE, since evidence using this mode of NIV is more robust in this population; however some patients may be initiated on bilevel NIV (eg, patients with acute hypercapnia due to ACPE).
        </p>
        <p>
         The impact of NIV on mortality in patients with ACPE is variable and may relate to differences in the type of NIV used and the presence or absence of acute hypercapnia. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 13 trials that included 1369 patients found that patients with ACPE who received CPAP plus standard care had a lower hospital mortality than those who received standard care alone (10.3 versus 15.8 percent; RR 0.64, 95% CI 0.44-0.92) [
         <a href="#rid19">
          19
         </a>
         ]. However, in the same analysis, treatment with bilevel NIV (nine trials, 1091 patients) was only associated with a trend towards improved mortality that did not reach statistical significance (9.6 versus 11.9 percent; RR 0.82, 95% CI 0.58-1.15).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Several studies found that patients with ACPE who present with acute hypercapnic respiratory failure derive the greatest mortality benefit, although this benefit has not been directly attributed to CPAP or bilevel NIV [
         <a href="#rid22">
          22,24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A randomized trial that compared CPAP with PSV delivered noninvasively found no difference in either mortality or the frequency of intubations, although respiratory distress appeared to resolve sooner among patients who received PSV, probably because it is a more comfortable mode of ventilation [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The practical aspects of applying CPAP and the medical treatment of acute decompensated heart failure are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Continuous positive airway pressure (CPAP)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3454.html" rel="external">
          "Treatment of acute decompensated heart failure: General considerations"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3700955869">
         <span class="h1">
          PATIENTS LESS LIKELY TO BENEFIT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other conditions where NIV may be initiated but data to confirm its efficacy are less robust, lacking, or conflicting include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute hypoxemic nonhypercapnic respiratory failure due to conditions other than acute cardiogenic pulmonary edema (ACPE) (see
         <a class="local">
          'Hypoxemic nonhypercapnic respiratory failure not due to ACPE'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute respiratory failure due to asthma exacerbation (see
         <a class="local">
          'Asthma exacerbation'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postextubation, postoperative, or chest trauma-induced acute respiratory failure (see
         <a class="local">
          'Others'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4003982024">
         <span class="h2">
          Hypoxemic nonhypercapnic respiratory failure not due to ACPE
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with hypoxemic respiratory failure
         <strong>
          not
         </strong>
         due to ACPE, an individualized approach is reasonable given the heterogeneity of the population and conflicting evidence among select populations. Choices include high-flow oxygen delivered via a nasal cannulae (HFNC), NIV, or low-flow oxygen. We prefer NIV or HFNC rather than low-flow oxygen. Choosing either option in this population should take into consideration the etiology of hypoxemic respiratory failure [
         <a href="#rid26">
          26
         </a>
         ]. If either HFNC or NIV is chosen, it is prudent to start
         <strong>
          early
         </strong>
         and have a low threshold to perform intubation. Further details regarding HFNC are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/134329.html" rel="external">
          "Evaluation and management of the nonventilated, hospitalized adult patient with acute hypoxemia", section on 'Humidified, high-flow oxygen delivered via nasal cannulae (HFNC)'
         </a>
         .)
        </p>
        <p>
         This cautious approach to NIV is because data are not as supportive in this population compared with patients who have acute hypercapnic respiratory failure due to an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) or acute respiratory failure due to ACPE. Consequently, the benefit from NIV likely varies. The variable response may be due to the wide range of underlying etiologies. For example, a prospective observational study reported a failure rate of 61 percent for those with acute respiratory failure due to septic shock compared with 23 percent in those with acute respiratory failure who did not have sepsis [
         <a href="#rid27">
          27
         </a>
         ]. In addition, limited data suggest a high failure rate of NIV in patients with Middle East respiratory syndrome (MERS) [
         <a href="#rid28">
          28
         </a>
         ] and influenza [
         <a href="#rid29">
          29
         </a>
         ]; as a consequence NIV is typically avoided in patients with acute hypoxemic respiratory failure from coronavirus disease 2019 (COVID-19). (See
         <a class="medical medical_review" href="/z/d/html/131226.html" rel="external">
          "COVID-19: Respiratory care of the nonintubated hypoxemic adult (supplemental oxygen, noninvasive ventilation, and intubation)", section on 'Choosing oxygen via high-flow nasal cannulae versus noninvasive ventilation'
         </a>
         .)
        </p>
        <p>
         There is conflicting evidence about whether NIV is beneficial to patients with hypoxemic nonhypercapnic respiratory failure not due to ACPE [
         <a href="#rid30">
          30-39
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 11 studies that excluded patients with AECOPD and ACPE showed that NIV reduced the intubation rate (relative risk [RR] 0.59, 95% CI 0.44-0.79) and hospital mortality (RR 0.46, 95% CI 0.24-0.87) compared with low-flow oxygen [
         <a href="#rid37">
          37
         </a>
         ]. However, confidence intervals are wide suggesting that benefit from NIV likely varies among individuals.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A network meta-analysis (NMA) of 25 randomized trials examined outcomes in patients with acute hypoxemic respiratory failure who were treated with noninvasive modalities (helmet NIV, face mask NIV and high-flow oxygen delivered via nasal cannula [HFNC]) and compared them with patients who were treated with low-flow oxygen [
         <a href="#rid40">
          40
         </a>
         ]. Mortality was lower in patients treated with helmet or face mask NIV compared with low-flow oxygen (helmet NIV: RR 0.40, 95% CI 0.24-0.6, absolute risk difference -0.19, low certainty; face mask NIV: RR 0.83, 95% CI 0.68-0.99, absolute risk difference -0.06, moderate certainty). All three noninvasive modalities reduced intubation rates (helmet NIV: RR 0.26, 95% CI 0.14-0.46, absolute risk difference -0.32, low certainty; face mask NIV: RR 0.76, 95% CI 0.62-0.90, absolute risk difference -0.12, moderate certainty; HFNC, RR, 0.76, 95% CI 0.55-0.99, absolute risk difference -0.11; moderate certainty). However, this NMA should be interpreted with caution since there was significant heterogeneity and risk of bias due to lack of blinding, as well as a wide range of etiologies for respiratory failure and illness severity among the included studies. In addition, the mortality benefit was not found among patients with severe hypoxemia (eg, arterial oxygen tension/fraction of inspired oxygen ratio &lt;200 mmHg).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a meta-analysis of 29 randomized trials of mixed population of patients with acute respiratory failure, HFNC was compared with NIV [
         <a href="#rid41">
          41
         </a>
         ]. HFNC resulted in lower mortality (RR 0.44, 95% CI 0.24-0.79), intubation rate (RR 0.71, 95%CI 0.53-0.95), and possibly hospital acquired pneumonia (RR 0.46, 95% CI 0.15-1.45) and improved patient comfort. However, small sample size and heterogeneity in study design, patient population characteristics, type of respiratory failure, and outcomes limit interpretation of the analysis. Despite these limitations, we agree that HFNC appears to be at least non-inferior and is an acceptable choice clinically in this setting.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Helmet NIV has been compared with HFNC in another small study of severely hypoxemic patients [
         <a href="#rid42">
          42
         </a>
         ]. Helmet NIV resulted in greater improvements in oxygenation, reduction in dyspnea and respiratory effort, and similar levels of arterial carbon dioxide tension. The role of helmet NIV in COVID-19 is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/131226.html" rel="external">
          "COVID-19: Respiratory care of the nonintubated hypoxemic adult (supplemental oxygen, noninvasive ventilation, and intubation)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         If NIV is chosen, we generally prefer bilevel positive airway pressure (BPAP) since it is better studied than other modes, and experience with its use is more widespread. Randomized trials that compared standard therapy alone with standard therapy plus NIV in patients with acute respiratory failure found that NIV improved outcomes when any of the following modes were used: assist control (AC) [
         <a href="#rid43">
          43
         </a>
         ], pressure support ventilation (PSV) [
         <a href="#rid5">
          5
         </a>
         ], or bilevel NIV [
         <a href="#rid30">
          30,31,44,45
         </a>
         ]. Three randomized trials demonstrated that proportional assist ventilation (PAV) and PSV had similar impact on intubation rates and mortality [
         <a href="#rid46">
          46-48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1651.html" rel="external">
          "Modes of mechanical ventilation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H454065754">
         <span class="h3">
          Acute nonhypercapnic respiratory failure due to AECOPD
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with acute nonhypercapnic respiratory failure due to acute exacerbation of chronic obstructive pulmonary disease (AECOPD), the derived benefit from bilevel NIV is uncertain compared with patients who have acute hypercapnic respiratory failure due to AECOPD. We agree with the American Thoracic Society guideline group who suggest
         <strong>
          not
         </strong>
         using NIV in this population [
         <a href="#rid1">
          1
         </a>
         ]. The recommendation was conditional and of low certainty. Data that support not administering NIV in this population include several small randomized or prospective trials that reported poor tolerance of bilevel NIV as well as no impact of NIV on mortality and conflicting effects on intubation rates in patients with AECOPD who did not have pronounced respiratory acidosis [
         <a href="#rid12">
          12,49-52
         </a>
         ]. However, several patients had mild acidosis and in some studies NIV was started late, which limits interpretation of these data. However, it may be tried on an individualized basis in an effort to prevent the development of acute hypercapnia.
        </p>
        <p class="headingAnchor" id="H514497607">
         <span class="h3">
          Pneumonia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Benefit from NIV in patients with pneumonia is variable.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some data suggest that bilevel NIV is beneficial in patients with acute hypoxemic respiratory failure due to pneumonia provided they are able to manage their secretions [
         <a href="#rid30">
          30,53-57
         </a>
         ]. In one trial that demonstrated benefit from NIV in patients with acute hypoxemic respiratory failure of varying etiologies, the mortality benefit and reduced intubation rate associated with NIV use were most evident in the subgroup of patients with pneumonia [
         <a href="#rid30">
          30
         </a>
         ]. In another database analysis of 1109 patients with acute respiratory failure due to pneumonia, improved survival was reported in those who had coexistent COPD or heart failure rather than those without COPD or heart failure [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with community acquired pneumonia (CAP), several small randomized trials have also reported that NIV resulted in decreased intensive care unit (ICU) mortality [
         <a href="#rid54">
          54
         </a>
         ], decreased intubation rate [
         <a href="#rid54">
          54,55
         </a>
         ], and improved oxygenation [
         <a href="#rid30">
          30,54-56
         </a>
         ] compared with standard therapy. However, older patients may not derive the same benefit; in a large database analysis, NIV was reported as less effective in patients older than 65 years who have acute respiratory failure due to pneumonia [
         <a href="#rid57">
          57
         </a>
         ]. In another meta-analysis of four randomized trials containing a total of 218 patients with CAP, NIV reduced the intubation rate (RR 0.46, 95% CI 0.26-0.79) and ICU mortality rate (RR 0.3, 95% CI 0.09-0.93) [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In contrast, limited data suggest a high failure rate of NIV in patients with MERS [
         <a href="#rid28">
          28
         </a>
         ] and influenza [
         <a href="#rid29">
          29
         </a>
         ]; as a consequence NIV is typically avoided in patients with acute hypoxemic respiratory failure from MERS and influenza. However, NIV may be beneficial in patients with COVID-19. (See
         <a class="medical medical_review" href="/z/d/html/131226.html" rel="external">
          "COVID-19: Respiratory care of the nonintubated hypoxemic adult (supplemental oxygen, noninvasive ventilation, and intubation)", section on 'Choosing oxygen via high-flow nasal cannulae versus noninvasive ventilation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1674068700">
         <span class="h3">
          Immunocompromised patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although NIV is frequently used in immunocompromised patients for the treatment of acute hypoxemic respiratory failure, data are conflicting. Reasons for this are unknown but may be due to the wide array of etiologies of acute respiratory failure in patients who are immunosuppressed or the higher likelihood that acute respiratory failure will progress due to the immunosuppression itself. We administer bilevel NIV cautiously in this population ensuring that patients are aggressively monitored, typically in the ICU, and that the threshold for intubation remains low.
        </p>
        <p>
         Data describing conflicting outcomes in patients with acute respiratory failure who are immunosuppressed include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Several small randomized studies in immunocompromised patients with acute hypoxemic nonhypercapnic respiratory failure report that compared with invasive mechanical ventilation or oxygen (typically low-flow oxygen), NIV is associated with decreased ICU mortality, intubation rate, and ICU length of stay [
         <a href="#rid54">
          54,60-62
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In contrast, several trials have shown no benefit and possibly harm with use of NIV as a first-line therapy in this population:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A large randomized trial in immunocompromised patients with acute hypoxemic nonhypercapnic respiratory failure reported that compared with oxygen alone, the early administration of NIV did not reduce 28-day mortality [
         <a href="#rid63">
          63
         </a>
         ]. However, a high proportion (44 percent) of patients in the oxygen group received oxygen via high-flow nasal cannulae (HFNC); thus, the administration of positive end-expiratory pressure (PEEP) from HFNC may have limited the ability of this trial to detect a benefit from NIV. Details regarding the mechanisms and benefits of HFNC are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/114077.html" rel="external">
          "Heated and humidified high-flow nasal oxygen in adults: Practical considerations and potential applications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a randomized trial of unselected patients with hypoxemic nonhypercapnic respiratory failure [
         <a href="#rid26">
          26
         </a>
         ], a post-hoc analysis of the 82 patients who were immunocompromised reported an increase in the rate of intubation in those treated with NIV as a first-line therapy, compared with HFNC (65 versus 43 percent) [
         <a href="#rid64">
          64
         </a>
         ]. Large tidal volumes were observed in the NIV group [
         <a href="#rid65">
          65
         </a>
         ] and the use of NIV was an independent predictor for the likelihood of requiring mechanical ventilation. However, methodologic flaws in this study prohibit firm conclusions regarding the potential harm of NIV.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a randomized trial of 300 immunocompromised patients that compared NIV (minimum of 12 hours) alternating with HFNC with HFNC alone, no difference in mortality or intubation rates was found [
         <a href="#rid66">
          66
         </a>
         ]. HFNC was more comfortable.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Several observational studies also suggest that a significant proportion of immunocompromised patients with acute respiratory failure do not benefit from NIV [
         <a href="#rid67">
          67-70
         </a>
         ]. As an example, in an observational study of 99 patients with hematologic malignancy and acute respiratory failure, approximately one-half of patients failed a trial of NIV and required endotracheal intubation [
         <a href="#rid67">
          67
         </a>
         ]. The patients who failed NIV had a higher hospital mortality, a longer duration of ICU stay, and a greater risk of nosocomial infection than those who were successfully treated with NIV.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1685399888">
         <span class="h3">
          Acute respiratory distress syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients with acute respiratory distress syndrome (ARDS) require invasive mechanical ventilation. However, we reserve bilevel NIV for the occasional patient with mild ARDS who is hemodynamically stable, easily oxygenated, and has no contraindications to its use. The limited evidence that describes NIV use in this population is conflicting and is described separately. (See
         <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">
          "Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Selecting invasive versus noninvasive ventilation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1637599999">
         <span class="h3">
          Asthma exacerbation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bilevel NIV is commonly used in patients with acute hypoxemic respiratory failure from severe asthma exacerbation. However, data are limited to small randomized trials, one meta-analysis of these trials, and large retrospective study that have not documented a clear, convincing, or consistent benefit on mortality or intubation rates [
         <a href="#rid71">
          71-78
         </a>
         ]. Despite inconclusive data, we suggest that a short trial of NIV (eg, one to two hours, typically BPAP) is appropriate in this population, particularly for those failing medical therapy. However, the threshold to intubate should be low. (See
         <a class="medical medical_review" href="/z/d/html/570.html" rel="external">
          "Invasive mechanical ventilation in adults with acute exacerbations of asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Bilevel noninvasive ventilation'
         </a>
         .)
        </p>
        <p>
         In support of this approach is one trial of 30 patients who presented to the emergency department with a severe asthma exacerbation that was not responding to inhaled bronchodilator therapy [
         <a href="#rid72">
          72
         </a>
         ]. Patients were randomly assigned to receive bilevel NIV or sham (subtherapeutic bilevel NIV) [
         <a href="#rid72">
          72
         </a>
         ]. Bilevel NIV was associated with a reduction in the rate of hospitalization (18 versus 63 percent) and improved predicted forced expiratory volume in one second (FEV
         <sub>
          1
         </sub>
         ; 80 versus 20 percent). However, in a meta-analysis of five trials, that included this trial, NIV did not reduce the intubation rate; mortality could not be assessed since there were no deaths in any of the studies analyzed [
         <a href="#rid77">
          77
         </a>
         ]. Thus, larger randomized studies are needed to determine the value of NIV in patients with acute respiratory failure due to an acute asthma exacerbation.
        </p>
        <p class="headingAnchor" id="H2282748489">
         <span class="h2">
          Others
         </span>
        </p>
        <p class="headingAnchor" id="H859624960">
         <span class="h3">
          Postextubation respiratory failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         NIV has been used in patients who develop acute respiratory failure in the first 24 to 72 hours following extubation. NIV has also been used as a tool to
         <strong>
          prevent
         </strong>
         reintubation in patients at high risk of developing acute respiratory failure following extubation; in that setting, NIV is typically compared or combined with oxygen delivered via HFNC. These data are described separately. (See
         <a class="medical medical_review" href="/z/d/html/1634.html" rel="external">
          "Extubation management in the adult intensive care unit", section on 'Patients with established postextubation respiratory failure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1634.html" rel="external">
          "Extubation management in the adult intensive care unit", section on 'Noninvasive ventilation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2973005195">
         <span class="h3">
          Postoperative respiratory failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         NIV has also been used to treat patients who develop acute respiratory failure in the postoperative setting, the details of which are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4401.html" rel="external">
          "Overview of the management of postoperative pulmonary complications", section on 'Postoperative respiratory failure'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1863554698">
         <span class="h3">
          Chest trauma-induced respiratory failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no specific contraindication to NIV in patients who develop acute respiratory failure following trauma to the chest [
         <a href="#rid35">
          35,79,80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/353.html" rel="external">
          "Initial evaluation and management of blunt thoracic trauma in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13862.html" rel="external">
          "Initial evaluation and management of penetrating thoracic trauma in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H490913284">
         <span class="h1">
          OTHER SETTINGS
         </span>
         <span class="headingEndMark">
          —
         </span>
         NIV has been traditionally used as an inpatient tool to treat acute respiratory failure in patients who are critically ill. However, NIV has been used in other clinical settings, none of which are routine (eg, oxygenation before and during intubation and palliative ventilation).
        </p>
        <p>
         Data that support prehospitalization use of NIV are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Timing, site, ancillary staff'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2697491860">
         <span class="h2">
          Oxygenation before and during intubation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prior to intubation, patients with hypoxemic respiratory failure are typically preoxygenated with 100 percent oxygen in order to prevent arterial oxygen desaturation during the procedure. NIV has been studied in this setting but is not routine. A randomized trial compared standard preoxygenation (with a bag mask valve) to preoxygenation with NIV [
         <a href="#rid81">
          81
         </a>
         ]. The NIV group had fewer oxyhemoglobin desaturations during intubation and a higher oxyhemoglobin saturation at the end of preoxygenation, during intubation, and following intubation. Other studies have described NIV as a tool to prevent desaturation during intubation, including nasal intubation [
         <a href="#rid82">
          82
         </a>
         ]. Preoxygenation and intubation support strategies are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/270.html" rel="external">
          "Rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H285932888">
         <span class="h2">
          Intubation refusal or palliation
         </span>
         <span class="headingEndMark">
          —
         </span>
         NIV has been used in patients who decline endotracheal intubation [
         <a href="#rid83">
          83-88
         </a>
         ]. Observational studies indicate that up to 43 percent of such patients survive to hospital discharge [
         <a href="#rid87">
          87,89
         </a>
         ]. However, the mortality rate during the next six months is high [
         <a href="#rid89">
          89
         </a>
         ]. NIV may also help reduce symptoms of dyspnea in patients receiving palliation for end-stage pulmonary diseases. Importantly, a do-not-intubate (DNI) order does not mean that NIV cannot be applied temporarily or palliatively. In an observational study of 36 patients with a DNI order, NIV delivered via an oronasal mask resulted in an improvement in eight patients while the remainder improved only after switching to a full-face mask [
         <a href="#rid90">
          90
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14238.html" rel="external">
          "Assessment and management of dyspnea in palliative care", section on 'Limited role for noninvasive ventilation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Interface (mask)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2280823298">
         <span class="h1">
          CONTRAINDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are several contraindications to NIV that are listed in the table  (
         <a class="graphic graphic_table graphicRef60442" href="/z/d/graphic/60442.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H3891748365">
         <span class="h2">
          Need for emergent intubation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The need for emergent intubation is an absolute contraindication to NIV (eg, cardiac or respiratory arrest, severe respiratory distress, unstable cardiac arrhythmias). (See
         <a class="medical medical_review" href="/z/d/html/268.html" rel="external">
          "The decision to intubate"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2095432746">
         <span class="h2">
          Others
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several other relative contraindications exist. NIV is generally avoided in such cases, but exceptions exist.
        </p>
        <p class="headingAnchor" id="H3775182371">
         <span class="h3">
          Acute life-threatening nonrespiratory organ failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nonrespiratory organ failure that is acutely life-threatening is a contraindication to NIV. There is considerable clinical judgement as to what constitutes acute life-threatening nonrespiratory organ failure but includes patients with severe encephalopathy, severe upper gastrointestinal bleeding (eg, variceal bleeding), and/or hemodynamic instability (eg, persistent hypotension unresponsive to fluid resuscitation or requiring vasoactive medication support).
        </p>
        <p class="headingAnchor" id="H3512863234">
         <span class="h3">
          Facial surgery or trauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with facial surgery or trauma are not typically candidates for NIV because the interface may fit poorly, cause discomfort, and/or potentially destabilize fractures or cause pneumocephalus. Similarly, patients with facial deformities may not be able to achieve an adequate interface fit, resulting in air leaks which diminish the efficacy of NIV. However, depending on the deformity location or severity of the injury, some patients may tolerate NIV if the optimal interface is chosen. For example, a patient with soft tissue injury only may tolerate a nasal mask while NIV should be avoided in a patient with multiple facial fractures or patients who require zygomatic wiring.
        </p>
        <p class="headingAnchor" id="H920685742">
         <span class="h3">
          Significant airway obstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with significant central lower airway obstruction (eg, tracheal tumor) or significant upper airway obstruction (eg, large laryngeal mass) are not suitable candidates for NIV since superior airway control is achieved, and in some cases, the obstruction can be bypassed with an invasive device (eg, endotracheal tube or tracheostomy).
        </p>
        <p class="headingAnchor" id="H1181776894">
         <span class="h3">
          Inability to protect the airway
         </span>
         <span class="headingEndMark">
          —
         </span>
         NIV increases the risk of aspiration due to gastric distension from pressurized air. Thus, patients who cannot protect their airway should not be treated with NIV. This includes patients with poor mental status who cannot cooperate with NIV, patients with high volumes of secretions, and patients with a weak or no cough reflex; the latter includes those with neuromuscular disorders, stroke, and patients with severely impaired consciousness (eg, Glasgow coma scale &lt;10  (
         <a class="graphic graphic_table graphicRef81854" href="/z/d/graphic/81854.html" rel="external">
          table 3
         </a>
         )).
        </p>
        <p>
         While most patients with severely impaired consciousness should not receive NIV, reduced consciousness due to hypercapnic encephalopathy may be an exception to the rule [
         <a href="#rid91">
          91-94
         </a>
         ]. This is because NIV is a treatment for acute hypercapnia; thus, mental status should improve with NIV. The likelihood that hypercapnic encephalopathy will respond to NIV is inversely related to the severity of the hypercapnia. [
         <a href="#rid93">
          93,94
         </a>
         ]. Such patients should be closely monitored (eg, in an intensive care or high dependency unit); improved consciousness should be apparent within one to two hours after the initiation of NIV. Patients who deteriorate or fail to improve should be promptly intubated.
        </p>
        <p class="headingAnchor" id="H71249779">
         <span class="h3">
          Prolonged duration of ventilation is anticipated
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical judgement is required when anticipating the duration of ventilation. Nonetheless, for patients with acute respiratory failure, NIV is generally considered as a short-term form of ventilation (eg, one to three days) while therapy for the underlying disorder is being treated. If it is anticipated that ventilation will be required for a more prolonged period (eg, ≥4 days), NIV is less appealing and patients should probably be intubated (eg, severe Guillain Barre syndrome). However, anecdotally, some patients with acute respiratory failure have been successfully treated with NIV for up to a week, especially if they are weaning and have "off" periods; in such cases, aggressive hourly monitoring and evaluation of the need for invasive ventilation should be performed, typically in an intensive care unit.
        </p>
        <p class="headingAnchor" id="H2858675144">
         <span class="h3">
          Recent esophageal or gastric anastomosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         We generally avoid NIV after upper gastrointestinal surgery (eg, gastric bypass, esophagectomy) that involves anastomoses, due to the possibility of gastric distention with leakage of gastric contents caused by the pressurized air. However, anecdotal experience and low quality evidence suggests that the risk of anastomotic dehiscence is low in this population. These data are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94348.html" rel="external">
          "Respiratory problems in the post-anesthesia care unit (PACU)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3222308046">
         <span class="h3">
          Multiple contraindications
         </span>
         <span class="headingEndMark">
          —
         </span>
         In reality, patients may have more than one contraindication to NIV. In such circumstances, we prefer to intubate these patients with a view to early extubation should they improve quickly.
        </p>
        <p class="headingAnchor" id="H3619702371">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/119337.html" rel="external">
          "Society guideline links: Noninvasive ventilation in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Noninvasive ventilation (NIV) is a form of positive pressure ventilation delivered through a noninvasive interface (eg, nasal mask, face mask, nasal plugs) that is frequently used to support patients with acute respiratory failure. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Choosing invasive versus noninvasive
         </strong>
         <strong>
          ventilation
         </strong>
         – When assessing patients for NIV, the clinician should identify whether the condition responsible for acute respiratory failure is typically responsive to NIV, evaluate for the presence of contraindications (including the emergent need for intubation)  (
         <a class="graphic graphic_table graphicRef60442" href="/z/d/graphic/60442.html" rel="external">
          table 2
         </a>
         ), and assess whether NIV suits the patient's preferences and values. (See
         <a class="local">
          'Choosing noninvasive versus invasive ventilation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The major benefit of NIV is the avoidance of intubation and risks of invasive mechanical ventilation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Since delayed mechanical ventilation is associated with a poor outcome, trials of NIV should be
         <strong>
          short
         </strong>
         (eg, two hours or less) and patients should be monitored and assessed frequently to ensure rapid intubation, when needed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         – A trial of NIV is worthwhile for the following patients with acute respiratory failure, provided there are no contraindications to NIV  (
         <a class="graphic graphic_table graphicRef60442" href="/z/d/graphic/60442.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Patients likely to benefit
         </strong>
         – Patients most likely to benefit include the following (see
         <a class="local">
          'Patients likely to benefit'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Acute hypercapnic respiratory failure due to an acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
         </strong>
         – For patients with acute hypercapnic respiratory failure (arterial tension of carbon dioxide [PaCO
         <sub>
          2
         </sub>
         ] &gt;45 mmHg [6 kPa] or pH &lt;7.30) due to an AECOPD, we recommend standard therapy plus a trial of bilevel NIV (also known as bilevel positive airway pressure [BPAP]) rather than standard therapy alone (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). Evidence from large randomized trials and meta-analyses consistently indicate that BPAP reduces mortality and the rate of intubation in this population. (See
         <a class="local">
          'Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with hypercapnic respiratory acidosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Acute respiratory failure from acute cardiogenic pulmonary edema (ACPE)
         </strong>
         – For patients with acute respiratory failure from ACPE, we recommend a trial of NIV (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). We prefer to initially use continuous positive airway pressure (CPAP), although some patients may also benefit from bilevel NIV (eg, patients with hypercapnia from ACPE). Evidence from small randomized trials and meta-analyses report that NIV decreases the need for intubation and improves clinical and laboratory indices of respiratory failure. NIV also reduces mortality in this population, although CPAP may have a greater impact than bilevel NIV. (See
         <a class="local">
          'Acute cardiogenic pulmonary edema (ACPE)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Patients less likely to benefit
         </strong>
         – Other patient populations are heterogeneous and have variable outcomes from NIV (see
         <a class="local">
          'Patients likely to benefit'
         </a>
         above and
         <a class="local">
          'Patients less likely to benefit'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Hypoxemic nonhypercapnic respiratory failure due to causes other than ACPE
         </strong>
         – For some patients with hypoxemic nonhypercapnic respiratory failure due to causes other than ACPE (eg, immunocompetent patients with pneumonia) who have failed low-flow oxygen, we suggest a trial of NIV or high-flow oxygen delivered via nasal cannulae (HFNC) before proceeding with invasive mechanical ventilation (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). In most cases, we prefer HFNC. This approach is based upon low quality evidence that suggests variability in the response to NIV or HFNC in this population and preliminary data that suggest HFNC may be superior. (See
         <a class="medical medical_review" href="/z/d/html/134329.html" rel="external">
          "Evaluation and management of the nonventilated, hospitalized adult patient with acute hypoxemia", section on 'Humidified, high-flow oxygen delivered via nasal cannulae (HFNC)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         It is particularly prudent in this population to start NIV or HFNC
         <strong>
          early
         </strong>
         , monitor aggressively (eg, in the intensive care unit), and to have a low threshold for intubation; this is especially true in immunocompromised patients, patients with acute respiratory distress syndrome (ARDS), and patients with viral pneumonitis (eg, Middle East respiratory syndrome, influenza, and COVID-2019) since these patient groups have a higher failure rate, with NIV in particular, and often progress to mechanical ventilation. (See
         <a class="local">
          'Hypoxemic nonhypercapnic respiratory failure not due to ACPE'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Acute nonhypercapnic respiratory failure due to AECOPD
         </strong>
         – In patients with acute nonhypercapnic respiratory failure due to AECOPD, we suggest
         <strong>
          not
         </strong>
         administering NIV (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ) due to a lack of benefit, although it may be tried on an individualized basis in an effort to prevent the development of acute hypercapnia. (See
         <a class="local">
          'Acute nonhypercapnic respiratory failure due to AECOPD'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Acute respiratory failure due to an asthma exacerbation
         </strong>
         – For patients with acute respiratory failure due to an asthma exacerbation who continue to have severe symptoms despite initial bronchodilator therapy, we suggest a trial of NIV rather than invasive mechanical ventilation (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). This approach is based upon limited data that suggest decreased hospitalization rates and improved lung function parameters in the absence of a clear impact on mortality or rate of intubation. (See
         <a class="local">
          'Asthma exacerbation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Special populations
         </strong>
         – Other applications of NIV include the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Extubation, chest trauma
         </strong>
         – In patients who develop acute respiratory failure following extubation or patients who are at high risk of respiratory failure following extubation and patients with chest trauma-related respiratory failure, a trial of NIV may be appropriate. (See
         <a class="medical medical_review" href="/z/d/html/1634.html" rel="external">
          "Extubation management in the adult intensive care unit", section on 'Postextubation management'
         </a>
         and
         <a class="local">
          'Others'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Oxygenation peri-intubation, palliation
         </strong>
         – In addition to treating acute respiratory failure in critically ill inpatients, NIV has also been used in other clinical settings, none of which are routine (eg, oxygenation before and during intubation and palliative ventilation). NIV has also been successfully used in the prehospital setting for the management of acute respiratory failure. (See
         <a class="local">
          'Other settings'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/126295.html" rel="external">
          "Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation", section on 'Timing, site, ancillary staff'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Contraindications
         </strong>
         – There are several contraindications to NIV  (
         <a class="graphic graphic_table graphicRef60442" href="/z/d/graphic/60442.html" rel="external">
          table 2
         </a>
         ). The need for emergent intubation is an absolute contraindication (eg, cardiac or respiratory arrest, severe respiratory distress, unstable cardiac arrhythmias). Relative contraindications include acute life-threatening nonrespiratory organ failure (eg, hemodynamic instability from variceal bleeding), facial abnormalities (eg, surgery, trauma, deformities), significant airway obstruction (eg, obstructing airway mass), inability to protect the airway (eg, patients with neuromuscular disorders, stroke, or severely impaired consciousness), prolonged duration of ventilatory support is anticipated, recent gastric or esophageal anastomoses, or the presence of more than one contraindication. (See
         <a class="local">
          'Contraindications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H516823111">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Kristy Bauman, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA 2000; 284:2361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walkey AJ, Wiener RS. Use of noninvasive ventilation in patients with acute respiratory failure, 2000-2009: a population-based study. Ann Am Thorac Soc 2013; 10:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sweet DD, Naismith A, Keenan SP, et al. Missed opportunities for noninvasive positive pressure ventilation: a utilization review. J Crit Care 2008; 23:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keenan SP, Sinuff T, Cook DJ, Hill NS. Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature. Ann Intern Med 2003; 138:861.
          </a>
         </li>
         <li class="breakAll">
          Williams JW, Cox CE, Hargett CW, et al. Noninvasive Positive-Pressure Ventilation (NPPV) for Acute Respiratory Failure. Duke Evidence-based Practice Center; Agency for Healthcare Research and Quality (US), Rockville, MD 2012.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindenauer PK, Stefan MS, Shieh MS, et al. Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med 2014; 174:1982.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osadnik CR, Tee VS, Carson-Chahhoud KV, et al. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 7:CD004104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diaz O, Iglesia R, Ferrer M, et al. Effects of noninvasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156:1840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ram FS, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004; :CD004104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keenan SP, Powers CE, McCormack DG. Noninvasive positive-pressure ventilation in patients with milder chronic obstructive pulmonary disease exacerbations: a randomized controlled trial. Respir Care 2005; 50:610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tajamul S, Hadda V, Madan K, et al. Neurally-Adjusted Ventilatory Assist Versus Noninvasive Pressure Support Ventilation in COPD Exacerbation: The NAVA-NICE Trial. Respir Care 2020; 65:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen KK, Jensen HI, Andersen TS, Christiansen CF. Intubation rate, duration of noninvasive ventilation and mortality after noninvasive neurally adjusted ventilatory assist (NIV-NAVA). Acta Anaesthesiol Scand 2020; 64:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masip J, Roque M, Sánchez B, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA 2005; 294:3124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winck JC, Azevedo LF, Costa-Pereira A, et al. Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema--a systematic review and meta-analysis. Crit Care 2006; 10:R69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collins SP, Mielniczuk LM, Whittingham HA, et al. The use of noninvasive ventilation in emergency department patients with acute cardiogenic pulmonary edema: a systematic review. Ann Emerg Med 2006; 48:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 2008; 359:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weng CL, Zhao YT, Liu QH, et al. Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema. Ann Intern Med 2010; 152:590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masip J, Betbesé AJ, Páez J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 2000; 356:2126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vital FM, Ladeira MT, Atallah AN. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev 2013; :CD005351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rusterholtz T, Kempf J, Berton C, et al. Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema (ACPE). Intensive Care Med 1999; 25:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Essam A, El Shebeiny A, Fathy R.. Non-Invasive Positive Pressure Ventilation or Standard Oxygen Therapy as Initial Treatment of Acute Cardiogenic Pulmonary Edema in ICU Patients. QJM 2023; 116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nava S, Carbone G, DiBattista N, et al. Noninvasive ventilation in cardiogenic pulmonary edema: a multicenter randomized trial. Am J Respir Crit Care Med 2003; 168:1432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nouira S, Boukef R, Bouida W, et al. Non-invasive pressure support ventilation and CPAP in cardiogenic pulmonary edema: a multicenter randomized study in the emergency department. Intensive Care Med 2011; 37:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372:2185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duan J, Chen L, Liang G, et al. Noninvasive ventilation failure in patients with hypoxemic respiratory failure: the role of sepsis and septic shock. Ther Adv Respir Dis 2019; 13:1753466619888124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 2016; 3:CD010406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferrer M, Esquinas A, Leon M, et al. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003; 168:1438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin TJ, Hovis JD, Costantino JP, et al. A randomized, prospective evaluation of noninvasive ventilation for acute respiratory failure. Am J Respir Crit Care Med 2000; 161:807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998; 339:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delclaux C, L'Her E, Alberti C, et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial. JAMA 2000; 284:2352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keenan SP, Sinuff T, Cook DJ, Hill NS. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med 2004; 32:2516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hernandez G, Fernandez R, Lopez-Reina P, et al. Noninvasive ventilation reduces intubation in chest trauma-related hypoxemia: a randomized clinical trial. Chest 2010; 137:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faria DA, da Silva EM, Atallah ÁN, Vital FM. Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery. Cochrane Database Syst Rev 2015; :CD009134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xu XP, Zhang XC, Hu SL, et al. Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis. Crit Care Med 2017; 45:e727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive-pressure ventilation in acute respiratory failure outside clinical trials: experience at the Massachusetts General Hospital. Crit Care Med 2008; 36:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chaudhuri D, Jinah R, Burns KEA, et al. Helmet noninvasive ventilation compared to facemask noninvasive ventilation and high-flow nasal cannula in acute respiratory failure: a systematic review and meta-analysis. Eur Respir J 2022; 59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferreyro BL, Angriman F, Munshi L, et al. Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis. JAMA 2020; 324:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baldomero AK, Melzer AC, Greer N, et al. Effectiveness and Harms of High-Flow Nasal Oxygen for Acute Respiratory Failure: An Evidence Report for a Clinical Guideline From the American College of Physicians. Ann Intern Med 2021; 174:952.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grieco DL, Menga LS, Raggi V, et al. Physiological Comparison of High-Flow Nasal Cannula and Helmet Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure. Am J Respir Crit Care Med 2020; 201:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993; 341:1555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wysocki M, Tric L, Wolff MA, et al. Noninvasive pressure support ventilation in patients with acute respiratory failure. A randomized comparison with conventional therapy. Chest 1995; 107:761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kramer N, Meyer TJ, Meharg J, et al. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995; 151:1799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gay PC, Hess DR, Hill NS. Noninvasive proportional assist ventilation for acute respiratory insufficiency. Comparison with pressure support ventilation. Am J Respir Crit Care Med 2001; 164:1606.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wysocki M, Richard JC, Meshaka P. Noninvasive proportional assist ventilation compared with noninvasive pressure support ventilation in hypercapnic acute respiratory failure. Crit Care Med 2002; 30:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-Vivas M, Caturla-Such J, González de la Rosa J, et al. Noninvasive pressure support versus proportional assist ventilation in acute respiratory failure. Intensive Care Med 2003; 29:1126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collaborative Research Group of Noninvasive Mechanical Ventilation for Chronic Obstructive Pulmonary Disease. Early use of non-invasive positive pressure ventilation for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial. Chin Med J (Engl) 2005; 118:2034.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bardi G, Pierotello R, Desideri M, et al. Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled study. Eur Respir J 2000; 15:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbé F, Togores B, Rubí M, et al. Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. Eur Respir J 1996; 9:1240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wood KA, Lewis L, Von Harz B, Kollef MH. The use of noninvasive positive pressure ventilation in the emergency department: results of a randomized clinical trial. Chest 1998; 113:1339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Y, Fang C, Dong BR, et al. Oxygen therapy for pneumonia in adults. Cochrane Database Syst Rev 2012; :CD006607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Confalonieri M, Potena A, Carbone G, et al. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med 1999; 160:1585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cosentini R, Brambilla AM, Aliberti S, et al. Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial. Chest 2010; 138:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valley TS, Walkey AJ, Lindenauer PK, et al. Association Between Noninvasive Ventilation and Mortality Among Older Patients With Pneumonia. Crit Care Med 2017; 45:e246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stefan MS, Priya A, Pekow PS, et al. The comparative effectiveness of noninvasive and invasive ventilation in patients with pneumonia. J Crit Care 2018; 43:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klefti G, Hill AT. The benefits of non-invasive ventilation for Community-Acquired Pneumonia: A meta-analysis. QJM 2020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Confalonieri M, Calderini E, Terraciano S, et al. Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystis carinii pneumonia. Intensive Care Med 2002; 28:1233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Antonelli M, Conti G, Bufi M, et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA 2000; 283:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang T, Zhang L, Luo K, et al. Noninvasive versus invasive mechanical ventilation for immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. BMC Pulm Med 2016; 16:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemiale V, Mokart D, Resche-Rigon M, et al. Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial. JAMA 2015; 314:1711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frat JP, Ragot S, Girault C, et al. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial. Lancet Respir Med 2016; 4:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frat JP, Ragot S, Coudroy R, et al. Tidal volume and non-invasive ventilation failure - Authors' reply. Lancet Respir Med 2016; 4:e52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coudroy R, Frat JP, Ehrmann S, et al. High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med 2022; 10:641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adda M, Coquet I, Darmon M, et al. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 2008; 36:2766.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Razlaf P, Pabst D, Mohr M, et al. Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsis. Respir Med 2012; 106:1509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azoulay E, Pickkers P, Soares M, et al. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 2017; 43:1808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gristina GR, Antonelli M, Conti G, et al. Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: a 5-year multicenter observational survey. Crit Care Med 2011; 39:2232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stefan MS, Nathanson BH, Lagu T, et al. Outcomes of Noninvasive and Invasive Ventilation in Patients Hospitalized with Asthma Exacerbation. Ann Am Thorac Soc 2016; 13:1096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003; 123:1018.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shivaram U, Miro AM, Cash ME, et al. Cardiopulmonary responses to continuous positive airway pressure in acute asthma. J Crit Care 1993; 8:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meduri GU, Cook TR, Turner RE, et al. Noninvasive positive pressure ventilation in status asthmaticus. Chest 1996; 110:767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patrick W, Webster K, Ludwig L, et al. Noninvasive positive-pressure ventilation in acute respiratory distress without prior chronic respiratory failure. Am J Respir Crit Care Med 1996; 153:1005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández MM, Villagrá A, Blanch L, Fernández R. Non-invasive mechanical ventilation in status asthmaticus. Intensive Care Med 2001; 27:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim WJ, Mohammed Akram R, Carson KV, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2012; 12:CD004360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Althoff MD, Holguin F, Yang F, et al. Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations. Am J Respir Crit Care Med 2020; 202:1520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bolliger CT, Van Eeden SF. Treatment of multiple rib fractures. Randomized controlled trial comparing ventilatory with nonventilatory management. Chest 1990; 97:943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gunduz M, Unlugenc H, Ozalevli M, et al. A comparative study of continuous positive airway pressure (CPAP) and intermittent positive pressure ventilation (IPPV) in patients with flail chest. Emerg Med J 2005; 22:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baillard C, Fosse JP, Sebbane M, et al. Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 2006; 174:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nong L, Liang W, Yu Y, et al. Noninvasive ventilation support during fiberoptic bronchoscopy-guided nasotracheal intubation effectively prevents severe hypoxemia. J Crit Care 2020; 56:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Antón A, Güell R, Gómez J, et al. Predicting the result of noninvasive ventilation in severe acute exacerbations of patients with chronic airflow limitation. Chest 2000; 117:828.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive pressure ventilation reverses acute respiratory failure in select "do-not-intubate" patients. Crit Care Med 2005; 33:1976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chu CM, Chan VL, Wong IW, et al. Noninvasive ventilation in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease who refused endotracheal intubation. Crit Care Med 2004; 32:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meduri GU, Fox RC, Abou-Shala N, et al. Noninvasive mechanical ventilation via face mask in patients with acute respiratory failure who refused endotracheal intubation. Crit Care Med 1994; 22:1584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy M, Tanios MA, Nelson D, et al. Outcomes of patients with do-not-intubate orders treated with noninvasive ventilation. Crit Care Med 2004; 32:2002.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azoulay E, Kouatchet A, Jaber S, et al. Noninvasive mechanical ventilation in patients having declined tracheal intubation. Intensive Care Med 2013; 39:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez R, Baigorri F, Artigas A. Noninvasive ventilation in patients with "do-not-intubate" orders: medium-term efficacy depends critically on patient selection. Intensive Care Med 2007; 33:350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemyze M, Mallat J, Nigeon O, et al. Rescue therapy by switching to total face mask after failure of face mask-delivered noninvasive ventilation in do-not-intubate patients in acute respiratory failure. Crit Care Med 2013; 41:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Díaz GG, Alcaraz AC, Talavera JC, et al. Noninvasive positive-pressure ventilation to treat hypercapnic coma secondary to respiratory failure. Chest 2005; 127:952.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scala R, Naldi M, Archinucci I, et al. Noninvasive positive pressure ventilation in patients with acute exacerbations of COPD and varying levels of consciousness. Chest 2005; 128:1657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Squadrone E, Frigerio P, Fogliati C, et al. Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance. Intensive Care Med 2004; 30:1303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paus-Jenssen ES, Reid JK, Cockcroft DW, et al. The use of noninvasive ventilation in acute respiratory failure at a tertiary care center. Chest 2004; 126:165.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 1636 Version 68.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28860265" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11066187" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23509327" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Use of noninvasive ventilation in patients with acute respiratory failure, 2000-2009: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18359428" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Missed opportunities for noninvasive positive pressure ventilation: a utilization review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7651472" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12779296" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12779296" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25347545" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28702957" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9412564" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Effects of noninvasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15266518" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15871754" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Noninvasive positive-pressure ventilation in patients with milder chronic obstructive pulmonary disease exacerbations: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31641071" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Neurally-Adjusted Ventilatory Assist Versus Noninvasive Pressure Support Ventilation in COPD Exacerbation: The NAVA-NICE Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31651041" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Intubation rate, duration of noninvasive ventilation and mortality after noninvasive neurally adjusted ventilatory assist (NIV-NAVA).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16380593" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16646987" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema--a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16934647" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The use of noninvasive ventilation in emergency department patients with acute cardiogenic pulmonary edema: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18614781" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Noninvasive ventilation in acute cardiogenic pulmonary edema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20439577" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11191538" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23728654" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10051074" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema (ACPE)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Non-Invasive Positive Pressure Ventilation or Standard Oxygen Therapy as Initial Treatment of Acute Cardiogenic Pulmonary Edema in ICU Patients
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12958051" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Noninvasive ventilation in cardiogenic pulmonary edema: a multicenter randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21136039" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Non-invasive pressure support ventilation and CPAP in cardiogenic pulmonary edema: a multicenter randomized study in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25981908" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31722614" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Noninvasive ventilation failure in patients with hypoxemic respiratory failure: the role of sepsis and septic shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24474051" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26950335" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Corticosteroids as adjunctive therapy in the treatment of influenza.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14500259" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10712326" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : A randomized, prospective evaluation of noninvasive ventilation for acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9700176" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11066186" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15599160" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19749006" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Noninvasive ventilation reduces intubation in chest trauma-related hypoxemia: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26436599" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28441237" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18091540" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Noninvasive positive-pressure ventilation in acute respiratory failure outside clinical trials: experience at the Massachusetts General Hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34413155" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Helmet noninvasive ventilation compared to facemask noninvasive ventilation and high-flow nasal cannula in acute respiratory failure: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32496521" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33900793" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Effectiveness and Harms of High-Flow Nasal Oxygen for Acute Respiratory Failure: An Evidence Report for a Clinical Guideline From the American College of Physicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31687831" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Physiological Comparison of High-Flow Nasal Cannula and Helmet Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8099639" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7874950" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Noninvasive pressure support ventilation in patients with acute respiratory failure. A randomized comparison with conventional therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7767523" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11719297" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Noninvasive proportional assist ventilation for acute respiratory insufficiency. Comparison with pressure support ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11889302" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Noninvasive proportional assist ventilation compared with noninvasive pressure support ventilation in hypercapnic acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12802487" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Noninvasive pressure support versus proportional assist ventilation in acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16438899" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Early use of non-invasive positive pressure ventilation for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10678628" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8804944" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9596317" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The use of noninvasive positive pressure ventilation in the emergency department: results of a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22419316" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Oxygen therapy for pneumonia in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11172189" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10556125" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20154071" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27749319" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Association Between Noninvasive Ventilation and Mortality Among Older Patients With Pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28915393" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : The comparative effectiveness of noninvasive and invasive ventilation in patients with pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32227219" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The benefits of non-invasive ventilation for Community-Acquired Pneumonia: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12209270" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystis carinii pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10634340" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27567894" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Noninvasive versus invasive mechanical ventilation for immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26444879" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27245914" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27799131" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Tidal volume and non-invasive ventilation failure - Authors' reply.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35325620" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18766110" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22944604" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28948369" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21666446" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: a 5-year multicenter observational survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27070493" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Outcomes of Noninvasive and Invasive Ventilation in Patients Hospitalized with Asthma Exacerbation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12684289" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8343867" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Cardiopulmonary responses to continuous positive airway pressure in acute asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8797425" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Noninvasive positive pressure ventilation in status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8630538" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Noninvasive positive-pressure ventilation in acute respiratory distress without prior chronic respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11355116" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Non-invasive mechanical ventilation in status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23235608" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32663410" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2182301" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Treatment of multiple rib fractures. Randomized controlled trial comparing ventilatory with nonventilatory management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15843697" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : A comparative study of continuous positive airway pressure (CPAP) and intermittent positive pressure ventilation (IPPV) in patients with flail chest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16627862" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31785505" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Noninvasive ventilation support during fiberoptic bronchoscopy-guided nasotracheal intubation effectively prevents severe hypoxemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10713013" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Predicting the result of noninvasive ventilation in severe acute exacerbations of patients with chronic airflow limitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16148468" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Noninvasive positive pressure ventilation reverses acute respiratory failure in select "do-not-intubate" patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14758150" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Noninvasive ventilation in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease who refused endotracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7924369" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Noninvasive mechanical ventilation via face mask in patients with acute respiratory failure who refused endotracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15483407" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Outcomes of patients with do-not-intubate orders treated with noninvasive ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23184037" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Noninvasive mechanical ventilation in patients having declined tracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17093982" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Noninvasive ventilation in patients with "do-not-intubate" orders: medium-term efficacy depends critically on patient selection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23263582" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Rescue therapy by switching to total face mask after failure of face mask-delivered noninvasive ventilation in do-not-intubate patients in acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15764781" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Noninvasive positive-pressure ventilation to treat hypercapnic coma secondary to respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16162772" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Noninvasive positive pressure ventilation in patients with acute exacerbations of COPD and varying levels of consciousness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15197438" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15249458" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : The use of noninvasive ventilation in acute respiratory failure at a tertiary care center.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
